Sunday, January 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Xenex Tests Germ-Zapping Robot Against Live Ebola and Anthrax

by Global Biodefense Staff
November 17, 2015

To validate how the Xenex Germ-Zapping Robot™ can be used for the decontamination of facilities, vehicles and equipment affected by a natural or intentional outbreak, Xenex Disinfection Services recently tested its device against live Ebola virus and Bacillus anthracis (anthrax) spores in collaboration with the biosafety level 4 (BSL-4) containment laboratory at Texas Biomedical Research Institute.

The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle without contact or chemicals.

The live agent study validated the efficacy of pulsed xenon UV light disinfection technology on two of the world’s deadliest pathogens.

In Texas Biomed’s BSL-4 lab, the Xenex robot destroyed both Ebola and anthrax spores on surfaces, achieving a greater than four-log reduction of Ebola in one minute and a greater than three-log reduction in anthrax spores in 15 minutes.

In none of the time/distance combinations was either anthrax or Ebola detected after the Xenex device was utilized.

“Xenex is an evidence-based company and this testing further validates that the Xenex Germ-Zapping Robot™ can be a critically important ally in the battle to stop the spread of high risk pathogens, especially as antibiotic resistance continues to mount,” said Dr. Mark Stibich, Chief Scientific Officer, Xenex.

More than 300 hospitals, Veterans Affairs, Department of Defense, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S., Europe, Canada and Africa use Xenex robots.

Source: Xenex press release, adapted.

Tags: AnthraxBiosafetyBioterrorismEbola

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC